loader image
Sunday, February 15, 2026
64.6 F
McAllen
- Advertisement -

New CEO Named at Texas Organ Sharing Alliance

Translate to Spanish or other 102 languages!

Joseph Nespral, MD, CPTC

Joseph Nespral is Longest-Serving OPO Clinical Director in Texas

Mega Doctors News –

- Advertisement -

San Antonio, TX — Texas Organ Sharing Alliance (TOSA), an organization providing organ donation services for families in Central and South Texas, has announced that Joseph Nespral, MD, CPTC, has been named the agency’s new Chief Executive Officer.

TOSA’s Board of Directors announced the selection recently to the organization’s staff. He replaces Patrick Giordano who served as CEO for nearly 20 years.

Nespral, who most recently served as TOSA’s interim CEO, is one of TOSA’s longest-tenured employees, hired in 1997. He is the longest-serving Clinical Director/Chief Operating Officer for an Organ Procurement Organization (OPO) in the State of Texas.

- Advertisement -

Before coming to TOSA, Nespral worked at OPOs across the country, including New York Organ Donor Network, LifeLink of Georgia and LifeLink of Puerto Rico. He has a degree in medicine from Central East University in the Dominican Republic and is a Board Certified Procurement Transplant Coordinator.

“I’ve had the privilege of working with our exceptional staff at TOSA, our generous donor families who provide a second chance to others and our transplant centers that work diligently to save their patients” said Nespral. “Now I look forward to leading our TOSA family as we continue to persevere in our mission to save more lives.”

Headquartered in San Antonio, TOSA facilitates organ donation services for families and thoughtful individuals who sought to become registered organ donors with the state’s official registry, Donate Life Texas. TOSA has been in San Antonio since 1975, servicing 56 counties with regional offices in Austin and the Rio Grande Valley. MDN

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

Breakthrough TTFields Technology Gets FDA Approval for Pancreatic Cancer Treatment

Mega Doctor News The U.S. Food and Drug Administration has approved a...

El Paso Researchers Advance New Treatments for Cancer and Heart Disease

Ramadevi Subramani Reddy, Ph.D., remembers the neem tree from her childhood in India — a plant her grandmother used to treat everything from fevers to infections.

STHS Heart Celebrates 30 Years of Cardiovascular Excellence

On January 15, 1996, South Texas Health System (STHS) Heart—then named McAllen Heart Hospital—opened as one of the...

Unexpected Cancer Drug Combo Shows Stronger Results Against Ovarian Tumors

A new study published by Mayo Clinic researchers suggests that ovarian cancer cells quickly activate a survival response after PARP inhibitor treatment, and blocking this early response may make this class of drugs work better.
- Advertisement -
×